Article
  • Transdermal Drug Release of Polymer Matrix of Unsaturated Poly(3-hydroxyalkanoate)
  • Lee SH, Shin BC, Rhee YH, Kim YW, Kim YB, Kim SS
  • 불포화 폴리(3-히드록시알칸오에이트)를 기질로 한 경피제제의 약물방출
  • 이수홍, 신병철, 이영하, 김형우, 김영백, 김승수
Abstract
Unsaturated poly(3-hydroxyalkanoate) (UPHA) was biosynthesized and the properties of drug delivery using the polymer matrix were investigated. The biosynthesis of UPHA was carried out by pH-stat fed batch fermentation of Pseudomonas oleovorans (ATCC 29347) grown solely with 10-undecenoic acid as a carbon source. The physical and chemical properties of the biosynethesized UPHA were characterized using NMR, FT-IR, GPC and DSC. The drug release experiments were carried out using HPLC with a diffusion cell for the release amount of ketoprofen as model drug. The effects of crosslinking degree, patch thickness, and enhancer on the drug release were studied. The drug release rate was linearly decreased and consistent with increased crosslinking degree of the polymer matrix. The duration of drug release was enhanced by the increased patch thickness. The drug release rate was increased with increased amount of propylene gylcol as an enhancer.

불포화 폴리(3-히드록시알칸오에이트) (UPHA)를 생합성하고 이 고분자 매트릭스 내에서의 약물방출 경향을 조사하였다. UPHA의 생합성에 사용된 균주는 Pseudomonas oleovorans (ATCC 29347)이고 탄소원은 10-undecenoic acid를 사용하였으며 산-염기조절방법 배취형태 발효법을 이용하여 미생물 배양을 행하였다. 생합성된 UPHA는 1H- 및 13C-NMR, FT-IR, GPC 및 DSC등을 사용하여 물리 및 화학적 분석을 행하였다. 약물방출 실험은 확산셀을 이용하여 모델약물인 케토프로펜의 방출량을 HPLC를 이용하여 측정하였고 UPHA의 가교도, 패취두께, 경피두께, 경피투과 향상제 등의 영향에 대하여 조사하였다. UPHA의 가교도의 증가에 따라 약물방출 속도가 늦어지고 약물방출 속도가 일정해지는 경향을 나타내었다.

Keywords: unsaturated poly(3-hydroxyalkanoate); drug delivery; transdermal; ketoprofen

  • Polymer(Korea) 폴리머
  • Frequency : Bimonthly(odd)
    ISSN 0379-153X(Print)
    ISSN 2234-8077(Online)
    Abbr. Polym. Korea
  • 2022 Impact Factor : 0.4
  • Indexed in SCIE

This Article

  • 2003; 27(6): 536-541

    Published online Nov 25, 2003

  • 10.7317/pk.
  • Received on May 19, 2003
  • Revised on Nov 30, -0001
  • Accepted on Oct 4, 2003

Correspondence to

  • E-mail: